Clinical Trial Update: Rapamycin vs Methotrexate in Diffuse SSc [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial comparing rapamycin versus methotrexate in diffuse systemic sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Systemic Sclerosis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Rapamycin (sirolimus)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Systemic Sclerosis | Phase 1, Phase 2 | Status: COMPLETED